Alpine Global Management, LLC Vertex Pharmaceuticals Inc Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 06, 2024	BUY	$314.42 - $351.91 $2.95 Million - $3.3 Million	9,375 New	9,375 $3.3 Million
Q2 2023 Nov 21, 2023	BUY	$314.42 - $351.91 $2.95 Million - $3.3 Million	9,375 New	9,375 $3.3 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.95 Million - $3.3 Million	9,375 New	9,375 $3.3 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $251,908 - $285,434	-1,835 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $271,818 - $297,710	1,835	1,835 $279,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.